JP2022523570A5 - - Google Patents
Info
- Publication number
- JP2022523570A5 JP2022523570A5 JP2021552816A JP2021552816A JP2022523570A5 JP 2022523570 A5 JP2022523570 A5 JP 2022523570A5 JP 2021552816 A JP2021552816 A JP 2021552816A JP 2021552816 A JP2021552816 A JP 2021552816A JP 2022523570 A5 JP2022523570 A5 JP 2022523570A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025050172A JP2025111445A (ja) | 2019-03-08 | 2025-03-25 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19161716.6 | 2019-03-08 | ||
| EP19161716 | 2019-03-08 | ||
| PCT/EP2020/055950 WO2020182635A1 (en) | 2019-03-08 | 2020-03-06 | Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050172A Division JP2025111445A (ja) | 2019-03-08 | 2025-03-25 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523570A JP2022523570A (ja) | 2022-04-25 |
| JP2022523570A5 true JP2022523570A5 (https=) | 2023-02-28 |
| JPWO2020182635A5 JPWO2020182635A5 (https=) | 2023-02-28 |
| JP7728704B2 JP7728704B2 (ja) | 2025-08-25 |
Family
ID=66000932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552816A Active JP7728704B2 (ja) | 2019-03-08 | 2020-03-06 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
| JP2025050172A Pending JP2025111445A (ja) | 2019-03-08 | 2025-03-25 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050172A Pending JP2025111445A (ja) | 2019-03-08 | 2025-03-25 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220152183A1 (https=) |
| EP (1) | EP3934696A1 (https=) |
| JP (2) | JP7728704B2 (https=) |
| CN (1) | CN114126662A (https=) |
| BR (1) | BR112021017239A2 (https=) |
| CA (1) | CA3131741A1 (https=) |
| MX (1) | MX2021010555A (https=) |
| WO (1) | WO2020182635A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202115151D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0220198D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Modified saccharides,conjugates thereof and their manufacture |
| ES2461350T3 (es) | 2003-01-30 | 2014-05-19 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
| GB0409750D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| JP6786394B2 (ja) | 2014-02-28 | 2020-11-18 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 改変髄膜炎菌ｆＨｂｐポリペプチド |
| GB202013262D0 (en) * | 2020-08-25 | 2020-10-07 | Glaxosmithkline Biologicals Sa | Vaccine Composition |
-
2020
- 2020-03-06 EP EP20708099.5A patent/EP3934696A1/en active Pending
- 2020-03-06 MX MX2021010555A patent/MX2021010555A/es unknown
- 2020-03-06 JP JP2021552816A patent/JP7728704B2/ja active Active
- 2020-03-06 CN CN202080031171.4A patent/CN114126662A/zh active Pending
- 2020-03-06 US US17/436,692 patent/US20220152183A1/en active Pending
- 2020-03-06 WO PCT/EP2020/055950 patent/WO2020182635A1/en not_active Ceased
- 2020-03-06 BR BR112021017239A patent/BR112021017239A2/pt unknown
- 2020-03-06 CA CA3131741A patent/CA3131741A1/en active Pending
-
2025
- 2025-03-25 JP JP2025050172A patent/JP2025111445A/ja active Pending